Dr. Madeleine Duvic: Profiling women dermatologists’ contributions to HIV research and treatment

Autor: David M. Weiner, AB, William D. James, MD

Publikováno v: International Journal of Women's Dermatology, Vol 8, Iss 3, p e019 (2022)

Externí odkaz: https://doaj.org/article/9402229f62d04503913606a6692146ff

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Clinical, Pathologic, and Imaging Variables Associated with Prostate Cancer Detection by PSMA PET/CT and Multiparametric MRI.

Autor: Sonni I; Department of Radiological Sciences, UCLA, Los Angeles, California; isonni@mednet.ucla.edu.; Department of Experimental and Clinical Medicine, University Magna Graecia, Catanzaro, Italy., Weiner AB; Department of Urology, UCLA, Los Angeles, California.; Institute for Precision Health, UCLA, Los Angeles, California., Doddipalli S; Department of Radiological Sciences, UCLA, Los Angeles, California., Deol M; Department of Radiological Sciences, UCLA, Los Angeles, California., Ban D; Department of Radiological Sciences, UCLA, Los Angeles, California., Kim HO; Department of Radiological Sciences, UCLA, Los Angeles, California., Grogan T; Department of Medicine Statistics Core, UCLA, Los Angeles, California., Ahuja P; Department of Radiological Sciences, UCLA, Los Angeles, California., Barroso N; Department of Radiological Sciences, UCLA, Los Angeles, California., Zong Y; Department of Pathology, UCLA, Los Angeles, California; and., Soin P; Department of Pathology, UCLA, Los Angeles, California; and., Sisk A; Department of Pathology, UCLA, Los Angeles, California; and., Czernin J; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California., Hsu W; Department of Radiological Sciences, UCLA, Los Angeles, California., Calais J; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California., Reiter RE; Department of Urology, UCLA, Los Angeles, California., Raman SS; Department of Radiological Sciences, UCLA, Los Angeles, California.

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Oct 30. Date of Electronic Publication: 2024 Oct 30.

Molecular Hallmarks of Prostate-specific Membrane Antigen in Treatment-naïve Prostate Cancer.

Autor: Weiner AB; Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA; Institute for Precision Health, University of California-Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA. Electronic address: abweiner@mednet.ucla.edu., Agrawal R; Institute for Precision Health, University of California-Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA; Department of Human Genetics, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA., Wang NK; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA; Department of Human Genetics, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA., Sonni I; Department of Radiological Sciences, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA; Department of Clinical and Experimental Medicine, University Magna Graecia, Catanzaro, Italy., Li EV; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Arbet J; Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA; Institute for Precision Health, University of California-Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA; Department of Human Genetics, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA., Zhang JJH; Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA., Proudfoot JA; Veracyte, Inc, San Diego, CA, USA., Hong BH; Division of Medical Sciences, National Cancer Centre Singapore, Singapore, Singapore., Davicioni E; Veracyte, Inc, San Diego, CA, USA., Kane N; Department of Radiation Oncology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA; Radiation Oncology Service, Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA., Valle LF; Department of Radiation Oncology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA; Radiation Oncology Service, Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA., Kishan AU; Department of Radiation Oncology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA., Pra AD; Department of Radiation Oncology, University of Miami Miller School of Medicine, Miami, FL, USA., Ghadjar P; Department of Radiation Oncology, Charité Universitätsmedizin Berlin, Berlin, Germany., Sweeney CJ; South Australian Immunogenomics Cancer Institute, University of Adelaide, Adelaide, SA, Australia., Nickols NG; Department of Radiation Oncology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA; Radiation Oncology Service, Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA., Karnes RJ; Department of Urology, Mayo Clinic, Rochester, MN, USA., Shen J; Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA; Department of Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA., Rettig MB; Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA; Department of Medicine, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA., Czernin J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA., Ross AE; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Lee Kiang Chua M; Divisions of Radiation Oncology and Medical Sciences, National Cancer Centre, Singapore, Singapore; Duke-NUS Medical School, Singapore, Singapore., Schaeffer EM; Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA., Boutros PC; Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA; Institute for Precision Health, University of California-Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA; Department of Human Genetics, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA., Reiter RE; Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, CA, USA; Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, CA, USA.

Publikováno v: European urology [Eur Urol] 2024 Sep 17. Date of Electronic Publication: 2024 Sep 17.

Transcriptomic Profiling of Primary Prostate Cancers and Nonlocalized Disease on Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography: A Multicenter Retrospective Study.

Autor: Nikitas J; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA., Subramanian K; Department of Nuclear Medicine, New York-Presbyterian/Weill Cornell Hospital, New York, NY., Gozal NB; Division of Urologic Surgery, Washington University School of Medicine, St Louis, MO., Ricaurte-Fajardo A; Department of Radiology, New York-Presbyterian/Weill Cornell Hospital, New York, NY., Li E; Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, IL., Proudfoot JA; Veracyte Inc, San Diego, CA., Davicioni E; Veracyte Inc, San Diego, CA., Marciscano AE; Department of Radiation Oncology, New York-Presbyterian Hospital/Weill Cornell Medical College, New York, NY., Osborne JR; Department of Radiology, New York-Presbyterian/Weill Cornell Hospital, New York, NY., Barbieri CE; Department of Urology, New York-Presbyterian/Weill Cornell Medical Center, New York, NY., Armstrong WR; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA., Smith CP; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA., Valle LF; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA.; Radiation Oncology Service, Greater Los Angeles Veterans Affairs Healthcare System, Los Angeles, CA., Steinberg ML; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA., Boutros PC; Department of Urology, University of California, Los Angeles, Los Angeles, CA., Nickols NG; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA., Rettig MB; Departments of Medicine and Urology, University of California, Los Angeles, Los Angeles, CA.; Division of Hematology-Oncology, Department of Medicine, VA Greater Los Angeles Healthcare System, Los Angeles, CA., Reiter R; Department of Urology, University of California, Los Angeles, Los Angeles, CA., Weiner AB; Department of Urology, University of California, Los Angeles, Los Angeles, CA.; Institute for Precision Health, University of California, Los Angeles, Los Angeles, CA., Calais J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA., Czernin J; Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA., Ross AE; Department of Urology, Northwestern University, Feinberg School of Medicine, Chicago, IL., Kim EH; Division of Urology, Department of Surgery, University of Nevada Reno School of Medicine, Reno, NV.; Department of Physiology and Cell Biology, University of Nevada Reno School of Medicine, Reno, NV., Nagar H; Department of Radiation Oncology, New York-Presbyterian Hospital/Weill Cornell Medical College, New York, NY., Kishan AU; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA.; Department of Urology, University of California, Los Angeles, Los Angeles, CA.

Publikováno v: JCO precision oncology [JCO Precis Oncol] 2024 Jul; Vol. 8, pp. e2400161.